tiprankstipranks
Advertisement
Advertisement
Genscript flags 2025 loss on Legend impairment despite surge in licensing profit
PremiumCompany AnnouncementsGenscript flags 2025 loss on Legend impairment despite surge in licensing profit
1M ago
Genscript Flags Legend Biotech’s 2025 Results, Cautions Investors on Risk
Premium
Company Announcements
Genscript Flags Legend Biotech’s 2025 Results, Cautions Investors on Risk
1M ago
Genscript Biotech Sets March Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
Genscript Biotech Sets March Board Meeting to Approve 2025 Annual Results
1M ago
Legend Biotech Unveils Promising Data at 2025 ASH Meeting
PremiumCompany AnnouncementsLegend Biotech Unveils Promising Data at 2025 ASH Meeting
4M ago
Genscript Biotech Announces Q3 2025 Results for Legend Biotech
Premium
Company Announcements
Genscript Biotech Announces Q3 2025 Results for Legend Biotech
5M ago
Genscript Biotech’s Associate to Present New Data at Hematology Meeting
Premium
Company Announcements
Genscript Biotech’s Associate to Present New Data at Hematology Meeting
5M ago
Genscript Biotech Reports Strong Revenue Growth Amid Strategic Investments
PremiumCompany AnnouncementsGenscript Biotech Reports Strong Revenue Growth Amid Strategic Investments
8M ago
Genscript Biotech Reports Strong Revenue and Profit Growth in H1 2025
Premium
Company Announcements
Genscript Biotech Reports Strong Revenue and Profit Growth in H1 2025
8M ago
Genscript Biotech’s Associate Legend Biotech Reports Q2 2025 Financial Results
Premium
Company Announcements
Genscript Biotech’s Associate Legend Biotech Reports Q2 2025 Financial Results
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100